Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Madrid, Spain, Es
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.tetraneuron.com
- Keywords
- alzheimer, terapia genica, gene therapy, disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, pioneering.
- HQ
- Madrid, Spain
Tetraneuron Questions
Tetraneuron's website is http://www.tetraneuron.com
Tetraneuron's LinkedIn profile is https://es.linkedin.com/company/tetraneuron
Tetraneuron has
17 employees.
View email and phone details for 17
employees at Tetraneuron.
Tetraneuron's industry is
Pharmaceutical Manufacturing
Tetraneuron's top competitors are
Biohope,
Geistek Pharmaceuticals,
Netmentora Catalunya,
Seccuri,
Johnson & Johnson Innovative Medicine,
Oncovision,
Superlativa,
Ysotope Theranostics,
Idoven,
Mendel Brain.
Tetraneuron's categories are Pharmaceutical Manufacturing
Tetraneuron's founding year is 2012
